Dynamics of abdominal symptoms during the start of a new therapy with Elexacaftor/Tezacaftor/Ivacaftor using the novel CFAbd-day2day questionnaire
暂无分享,去创建一个
J. Mainz | O. Eickmeier | C. Schwarz | L. Nährlich | P. Eschenhagen | Pu Huang | U. Graepler-Mainka | C. Zagoya | A. Barucha | S. Lüth | L. Bechinger | Franziska Duckstein | L. Polte | P. Sadrieh | S. V. Dullemen